# | Title | Journal | Year | Citations |
---|
1 | Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes | Yearbook of Endocrinology | 2008 | 272 |
2 | Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma | Yearbook of Endocrinology | 2009 | 165 |
3 | Economic Costs of Diabetes in the U.S. in 2007 | Yearbook of Endocrinology | 2008 | 105 |
4 | Pseudohypoparathyroidism and GNAS Epigenetic Defects: Clinical Evaluation of Albright Hereditary Osteodystrophy and Molecular Analysis in 40 Patients | Yearbook of Endocrinology | 2010 | 88 |
5 | Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes | Yearbook of Endocrinology | 2008 | 30 |
6 | Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions | Yearbook of Endocrinology | 2008 | 27 |
7 | Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial | Yearbook of Endocrinology | 2007 | 25 |
8 | Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Yearbook of Endocrinology | 2006 | 10 |
9 | A PGC1–α–dependent myokine that drives brown–fat–like development of white fat and thermogenesis | Yearbook of Endocrinology | 2012 | 7 |
10 | Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins | Yearbook of Endocrinology | 2007 | 7 |
11 | Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes | Yearbook of Endocrinology | 2009 | 5 |
12 | Human gut microbes associated with obesity | Yearbook of Endocrinology | 2007 | 3 |
13 | Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial | Yearbook of Endocrinology | 2009 | 3 |
14 | Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial | Yearbook of Endocrinology | 2009 | 3 |
15 | Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus | Yearbook of Endocrinology | 2010 | 3 |
16 | Improved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation | Yearbook of Endocrinology | 2012 | 3 |
17 | Obesity is associated with hypothalamic injury in rodents and humans | Yearbook of Endocrinology | 2012 | 3 |
18 | Management of type 2 diabetes: new and future developments in treatment | Yearbook of Endocrinology | 2012 | 3 |
19 | Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin | Yearbook of Endocrinology | 2006 | 2 |
20 | Primary Hyperparathyroidism in Pediatric Patients | Yearbook of Endocrinology | 2006 | 2 |
21 | Secondary Prevention of Macrovascular Events in Patients With Type 2 Diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macro Vascular Events): A Randomised Controlled Trial | Yearbook of Endocrinology | 2006 | 2 |
22 | Non—HDL Cholesterol, Apolipoproteins A-1 and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women | Yearbook of Endocrinology | 2006 | 2 |
23 | Meta-analysis: Pharmacologic Treatment of Obesity | Yearbook of Endocrinology | 2006 | 2 |
24 | Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial | Yearbook of Endocrinology | 2007 | 2 |
25 | Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids | Yearbook of Endocrinology | 2009 | 2 |
26 | 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes | Yearbook of Endocrinology | 2009 | 2 |
27 | Recurrence of Hyperprolactinemia following Withdrawal of Long-Term Cabergoline Therapy | Yearbook of Endocrinology | 2009 | 2 |
28 | RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact | Yearbook of Endocrinology | 2010 | 2 |
29 | Impact of the exon 3-deleted GH receptor polymorphism on baseline height and the growth response to recombinant human growth hormone therapy in growth hormone deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis | Yearbook of Endocrinology | 2010 | 2 |
30 | Sclerostin is a locally acting regulator of late-osteoblast/pre-osteocyte differentiation and regulates mineralization through a MEPE-ASARM dependent mechanism | Yearbook of Endocrinology | 2011 | 2 |
31 | Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death | Yearbook of Endocrinology | 2011 | 2 |
32 | Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis | Yearbook of Endocrinology | 2012 | 2 |
33 | The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial | Yearbook of Endocrinology | 2012 | 2 |
34 | Are Klinefelter boys hypogonadal? | Yearbook of Endocrinology | 2012 | 2 |
35 | On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy: JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) | Yearbook of Endocrinology | 2012 | 2 |
36 | An obesity-associated gut microbiome with increased capacity for energy harvest | Yearbook of Endocrinology | 2007 | 2 |
37 | Reductions in portion size and energy density of foods are additive and lead to sustained decreases in energy intake | Yearbook of Endocrinology | 2007 | 2 |
38 | Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-analysis of Randomized Clinical Trials | Yearbook of Endocrinology | 2006 | 1 |
39 | High Attributable Risk of Elevated C-Reactive Protein Level to Conventional Coronary Heart Disease Risk Factors: The Third National Health and Nutrition Examination Survey | Yearbook of Endocrinology | 2006 | 1 |
40 | Estrogen Replacement Therapy Increases Plasma Ghrelin Levels | Yearbook of Endocrinology | 2006 | 1 |
41 | Transsphenoidal Microsurgery for Cushing's Disease: Initial Outcome and Long-term Results | Yearbook of Endocrinology | 2006 | 1 |
42 | Sex Disparities in Treatment of Cardiac Risk Factors in Patients With Type 2 Diabetes | Yearbook of Endocrinology | 2006 | 1 |
43 | Essential Nutrients: Food or Supplements? Where Should the Emphasis Be? | Yearbook of Endocrinology | 2006 | 1 |
44 | Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients With Dyslipidemia | Yearbook of Endocrinology | 2006 | 1 |
45 | Spontaneous Normalization of Thyrotropin Concentrations in Patients With Subclinical Hypothyroidism | Yearbook of Endocrinology | 2006 | 1 |
46 | Long-term Follow-up Study of Radioiodine Treatment of Hyperthyroidism | Yearbook of Endocrinology | 2006 | 1 |
47 | Excess Aldosterone Under Normal Salt Diet Induces Cardiac Hypertrophy and Infiltration via Oxidative Stress | Yearbook of Endocrinology | 2006 | 1 |
48 | Insulin Resistance and Type 2 Diabetes in High-Fat-fed Mice Are Linked to High Glycotoxin Intake | Yearbook of Endocrinology | 2006 | 1 |
49 | Blockade of Endogenous Cytokines Mitigates Neointimal Formation in Obese Zucker Rats | Yearbook of Endocrinology | 2006 | 1 |
50 | Fast-Food Habits, Weight Gain, and Insulin Resistance (the CARDIA Study): 15-Year Prospective Analysis | Yearbook of Endocrinology | 2006 | 1 |